Type II Toxoplasma gondii Induction of CD40 on Infected Macrophages Enhances Interleukin-12 Responses
暂无分享,去创建一个
P. Casali | P. Morgado | J. Boyle | M. Lodoen | T. Lam | Lanny Gov | K. Harker | D.M. Sudarshana | Tonika Lam | L. Gov
[1] N. Ueno,et al. Human Innate Immunity to Toxoplasma gondii Is Mediated by Host Caspase-1 and ASC and Parasite GRA15 , 2013, mBio.
[2] G. Marth,et al. Genetic basis for phenotypic differences between different Toxoplasma gondii type I strains , 2013 .
[3] M. Yaffe,et al. The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response , 2012, PLoS pathogens.
[4] L. Opitz,et al. Impaired Chromatin Remodelling at STAT1-Regulated Promoters Leads to Global Unresponsiveness of Toxoplasma gondii-Infected Macrophages to IFN-γ , 2012, PLoS pathogens.
[5] Pedro Morgado,et al. Toxoplasma gondii Induces B7-2 Expression through Activation of JNK Signal Transduction , 2011, Infection and Immunity.
[6] H. Ploegh,et al. Determinants of GBP Recruitment to Toxoplasma gondii Vacuoles and the Parasitic Factors That Control It , 2011, PloS one.
[7] B. Butcher,et al. Toxoplasma gondii Rhoptry Kinase ROP16 Activates STAT3 and STAT6 Resulting in Cytokine Inhibition and Arginase-1-Dependent Growth Control , 2011, PLoS pathogens.
[8] Y. Chien,et al. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. , 2011, Cell host & microbe.
[9] J. Boothroyd,et al. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence , 2011, Proceedings of the National Academy of Sciences.
[10] J. Saeij,et al. Strain-specific activation of the NF-κB pathway by GRA15, a novel Toxoplasma gondii dense granule protein , 2011, The Journal of experimental medicine.
[11] G. Landreth,et al. The CD40-Autophagy Pathway Is Needed for Host Protection Despite IFN-Γ-Dependent Immunity and CD40 Induces Autophagy via Control of P21 Levels , 2010, PloS one.
[12] Michael S. Behnke,et al. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. , 2010, Cell host & microbe.
[13] Pjotr Prins,et al. R/qtl: high-throughput multiple QTL mapping , 2010, Bioinform..
[14] J. Boothroyd,et al. Association of host mitochondria with the parasitophorous vacuole during Toxoplasma infection is not dependent on rhoptry proteins ROP2/8. , 2010, International journal for parasitology.
[15] D. Maubon,et al. In Vitro Differential Phenotypic Characteristics Among Type-II Toxoplasma gondii Strains From Congenital Toxoplasmosis in Humans , 2010, The Journal of parasitology.
[16] D. Roos,et al. Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. , 2010, Cell host & microbe.
[17] Ian Parker,et al. Acquisition of chemiluminescent signals from immunoblots with a digital single-lens reflex camera. , 2010, Analytical biochemistry.
[18] J. Boothroyd,et al. Bradyzoite-Specific Surface Antigen SRS9 Plays a Role in Maintaining Toxoplasma gondii Persistence in the Brain and in Host Control of Parasite Replication in the Intestine , 2007, Infection and Immunity.
[19] J. Boothroyd,et al. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue , 2007, Nature.
[20] J. Ajioka,et al. Polymorphic Secreted Kinases Are Key Virulence Factors in Toxoplasmosis , 2006, Science.
[21] B. Striepen,et al. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. , 2006, The Journal of clinical investigation.
[22] Y. Yanagawa,et al. Distinct regulation of CD40‐mediated interleukin‐6 and interleukin‐12 productions via mitogen‐activated protein kinase and nuclear factor κB‐inducing kinase in mature dendritic cells , 2006, Immunology.
[23] C. Subauste,et al. CD40 Restrains In Vivo Growth of Toxoplasma gondii Independently of Gamma Interferon , 2006, Infection and Immunity.
[24] G. Bishop,et al. TNF Receptor-Associated Factor 6-Dependent CD40 Signaling Primes Macrophages to Acquire Antimicrobial Activity in Response to TNF-α1 , 2005, The Journal of Immunology.
[25] E. Benveniste,et al. LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia , 2005 .
[26] L. Lanier,et al. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12 , 2005, Nature Immunology.
[27] Ian T. Paulsen,et al. Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii , 2005, Nucleic acids research.
[28] C. Subauste,et al. CD40 Signaling in Macrophages Induces Activity against an Intracellular Pathogen Independently of Gamma Interferon and Reactive Nitrogen Intermediates , 2005, Infection and Immunity.
[29] A. D. Panopoulos,et al. Cutting Edge: IL-10-Independent STAT3 Activation by Toxoplasma gondii Mediates Suppression of IL-12 and TNF-α in Host Macrophages1 , 2005, The Journal of Immunology.
[30] A. Awasthi,et al. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses , 2004, Nature Medicine.
[31] A. Awasthi,et al. CD40 Signaling Is Impaired in L. major–infected Macrophages and Is Rescued by a p38MAPK Activator Establishing a Host-protective Memory T Cell Response , 2003, The Journal of experimental medicine.
[32] E. Pearce,et al. CD154 Plays a Central Role in Regulating Dendritic Cell Activation During Infections That Induce Th1 or Th2 Responses1 , 2003, The Journal of Immunology.
[33] T. Randall,et al. The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression , 2002, The Journal of experimental medicine.
[34] N. Munshi,et al. NF-κB as a Therapeutic Target in Multiple Myeloma* , 2002, The Journal of Biological Chemistry.
[35] C. Hunter,et al. Cutting Edge: Identification of c-Rel-Dependent and -Independent Pathways of IL-12 Production During Infectious and Inflammatory Stimuli1 , 2002, The Journal of Immunology.
[36] H. Waldmann,et al. The Role of Sp1 and NF-κB in Regulating CD40 Gene Expression* , 2002, The Journal of Biological Chemistry.
[37] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[38] V. Nguyen,et al. IL-4-Activated STAT-6 Inhibits IFN-γ-Induced CD40 Gene Expression in Macrophages/Microglia1 , 2000, The Journal of Immunology.
[39] A. Sher,et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. , 2000, Immunity.
[40] V. Nguyen,et al. Involvement of STAT-1 and Ets Family Members in Interferon-γ Induction of CD40 Transcription in Microglia/Macrophages* , 2000, The Journal of Biological Chemistry.
[41] A. Sher,et al. Cutting Edge: IL-12 Is Required for the Maintenance of IFN-γ Production in T Cells Mediating Chronic Resistance to the Intracellular Pathogen, Toxoplasma gondii , 2000, The Journal of Immunology.
[42] C. Hunter,et al. The CD40/CD40 Ligand Interaction Is Required for Resistance to Toxoplasmic Encephalitis , 2000, Infection and Immunity.
[43] R. Sorensen,et al. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. , 1999, Journal of immunology.
[44] J. Inoue,et al. Induction of interleukin‐12 p40 transcript by CD40 ligation via activation of nuclear factor‐xB , 1997, European journal of immunology.
[45] H. Nariuchi,et al. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. , 1996, Journal of immunology.
[46] J. Sun,et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. , 1996, Immunity.
[47] T. Horii,et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. , 1996, Immunity.
[48] K. Mohler,et al. CD40/CD40 ligand interactions are required for T cell‐dependent production of interleukin‐12 by mouse macrophages , 1996, European journal of immunology.
[49] E Stuber,et al. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion , 1996, The Journal of experimental medicine.
[50] J. Suttles,et al. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. , 1996, Journal of immunology.
[51] C. Hunter,et al. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha , 1994, Infection and immunity.
[52] I. Khan,et al. Interleukin-12 enhances murine survival against acute toxoplasmosis , 1994, Infection and immunity.
[53] L. David Sibley,et al. Virulent strains of Toxoplasma gondii comprise a single clonal lineage , 1992, Nature.
[54] A. Sher,et al. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.
[55] Y. Suzuki,et al. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. , 1988, Journal of immunology.
[56] R. Schreiber,et al. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. , 1988, Science.
[57] N. C. Smith,et al. The immunobiology of the innate response to Toxoplasma gondii. , 2009, International journal for parasitology.
[58] E. Benveniste,et al. LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. , 2005, Blood.
[59] N. Munshi,et al. NF-kappa B as a therapeutic target in multiple myeloma. , 2002, The Journal of biological chemistry.
[60] H. Waldmann,et al. The role of Sp1 and NF-kappa B in regulating CD40 gene expression. , 2002, The Journal of biological chemistry.
[61] V. Nguyen,et al. IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. , 2000, Journal of immunology.
[62] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .